FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283588045> ?p ?o ?g. }

• W4283588045 abstract "The publication of the fifth edition of the WHO classification of tumors of the central nervous system, first online at the end of 2021 and in print at the beginning of 2022, was a much awaited event in the brain tumor community. The remarkable pace of scientific advances that has increasingly refined our diagnostic approach to the various tumor types seems to have impacted the perceived time regarding expectations. The fourth edition was published in 2007 while a “revised” (not technically a new) edition was published in 2016, but so many advances have made the roughly 5 year wait seem a very long time. Fortunately, the timely publication of seven cIMPACT-NOW series, which has developed in the interim [1], and a preliminary summary of the WHO Classification proper [2] have supported diagnostic neuropathology practice to the benefit of the medical community and brain tumor patients. Tumors are organized in 13 major categories reflecting in part prior classifications (Figure 1). However, the effort of incorporating major molecular genetic drivers pioneered in the 4th classification (2016) has progressed and in particular, the input of epigenetic profiling chiefly obtained from methylation arrays has provided another important layer of information. In the minisymposium published in this issue of Brain Pathology, four practical review articles optimally illustrated and with useful guiding tables provide updates in the classification of major tumor categories relevant to diagnostic neuropathology as specified in the new WHO Classification. Whitfield BT et al., [3] discuss the current classification of diffuse gliomas in adults, including the role of ancillary molecular testing in identifying distinct tumor types (e.g., EGFR amplification, TERT promoter mutation, and +7/−10 in glioblastoma, IDH wildtype) and grading (homozygous CDKN2A/B homozygous deletion in IDH mutant astrocytomas). Bale TA et al., [4] summarize and address the challenges inherent to the expanding group of low-grade glial and glioneuronal tumors that affect children, another category of tumors where molecular diagnostics has played an important role in outlining new types. Kresbach C. et al., [5] cover important advances in the classification of ependymal neoplasms, a tumor group that best illustrates the updated model of the WHO classification, merging anatomic, histologic, immunohistochemical, sequencing, and epigenetic data into a powerful classification approach that has significantly improved prognostication. Finally, Meredith DM et al., [6] address the dual topics of embryonal neoplasms and non-meningothelial mesenchymal neoplasms. The latter group has been particularly timely, given that specific tumor types which may have counterparts in the broader field of soft tissue tumors have been teased out from historical CNS groups. Certainly, this minisymposium does not encompass all tumor groups and updates of the new WHO classification. Important topics such as pediatric high-grade gliomas and meningiomas are covered in other reviews [7] and even complete minisymposiums [8]. Additionally, challenges intrinsic to all molecular-based classifications remain, specifically difficulties in platform and bioinformatic standardization, as well as accessibility of novel diagnostic tests in underdeveloped, and sometimes even developed countries. In the spirit of the prior WHO, “not otherwise specified” options and long diagnostic comments are still available when thorough profiling resulting from large-scale groundbreaking studies are not possible in the individual case. Therefore, creativity in the design of surrogate markers and practical diagnostic approach guidelines should continue to be encouraged at the present time. None. Fausto Rodriguez: wrote manuscript and approved in final form. None." @default.
• W4283588045 created "2022-06-28" @default.
• W4283588045 creator A5002801148 @default.
• W4283588045 date "2022-06-26" @default.
• W4283588045 modified "2023-10-13" @default.
• W4283588045 title "The <scp>WHO</scp> classification of tumors of the central nervous system‐finally here, and welcome!" @default.
• W4283588045 cites W2566035051 @default.
• W4283588045 cites W3153732611 @default.
• W4283588045 cites W3174246647 @default.
• W4283588045 cites W4214644780 @default.
• W4283588045 cites W4214668334 @default.
• W4283588045 cites W4220730899 @default.
• W4283588045 cites W4220805597 @default.
• W4283588045 cites W4220890889 @default.
• W4283588045 doi "https://doi.org/10.1111/bpa.13077" @default.
• W4283588045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35754178" @default.
• W4283588045 hasPublicationYear "2022" @default.
• W4283588045 type Work @default.
• W4283588045 citedByCount "1" @default.
• W4283588045 countsByYear W42835880452023 @default.
• W4283588045 crossrefType "journal-article" @default.
• W4283588045 hasAuthorship W4283588045A5002801148 @default.
• W4283588045 hasBestOaLocation W42835880452 @default.
• W4283588045 hasConcept C111919701 @default.
• W4283588045 hasConcept C13280743 @default.
• W4283588045 hasConcept C142724271 @default.
• W4283588045 hasConcept C15744967 @default.
• W4283588045 hasConcept C166957645 @default.
• W4283588045 hasConcept C169760540 @default.
• W4283588045 hasConcept C187191949 @default.
• W4283588045 hasConcept C205649164 @default.
• W4283588045 hasConcept C2776957806 @default.
• W4283588045 hasConcept C2777526511 @default.
• W4283588045 hasConcept C2779130545 @default.
• W4283588045 hasConcept C2779134260 @default.
• W4283588045 hasConcept C2780130745 @default.
• W4283588045 hasConcept C41008148 @default.
• W4283588045 hasConcept C60644358 @default.
• W4283588045 hasConcept C71924100 @default.
• W4283588045 hasConcept C86803240 @default.
• W4283588045 hasConcept C95457728 @default.
• W4283588045 hasConceptScore W4283588045C111919701 @default.
• W4283588045 hasConceptScore W4283588045C13280743 @default.
• W4283588045 hasConceptScore W4283588045C142724271 @default.
• W4283588045 hasConceptScore W4283588045C15744967 @default.
• W4283588045 hasConceptScore W4283588045C166957645 @default.
• W4283588045 hasConceptScore W4283588045C169760540 @default.
• W4283588045 hasConceptScore W4283588045C187191949 @default.
• W4283588045 hasConceptScore W4283588045C205649164 @default.
• W4283588045 hasConceptScore W4283588045C2776957806 @default.
• W4283588045 hasConceptScore W4283588045C2777526511 @default.
• W4283588045 hasConceptScore W4283588045C2779130545 @default.
• W4283588045 hasConceptScore W4283588045C2779134260 @default.
• W4283588045 hasConceptScore W4283588045C2780130745 @default.
• W4283588045 hasConceptScore W4283588045C41008148 @default.
• W4283588045 hasConceptScore W4283588045C60644358 @default.
• W4283588045 hasConceptScore W4283588045C71924100 @default.
• W4283588045 hasConceptScore W4283588045C86803240 @default.
• W4283588045 hasConceptScore W4283588045C95457728 @default.
• W4283588045 hasIssue "4" @default.
• W4283588045 hasLocation W42835880451 @default.
• W4283588045 hasLocation W42835880452 @default.
• W4283588045 hasLocation W42835880453 @default.
• W4283588045 hasOpenAccess W4283588045 @default.
• W4283588045 hasPrimaryLocation W42835880451 @default.
• W4283588045 hasRelatedWork W139999544 @default.
• W4283588045 hasRelatedWork W1969630132 @default.
• W4283588045 hasRelatedWork W1978954528 @default.
• W4283588045 hasRelatedWork W2001050739 @default.
• W4283588045 hasRelatedWork W2409174684 @default.
• W4283588045 hasRelatedWork W3136021439 @default.
• W4283588045 hasRelatedWork W3206582313 @default.
• W4283588045 hasRelatedWork W4239271673 @default.
• W4283588045 hasRelatedWork W4240553834 @default.
• W4283588045 hasRelatedWork W4249345063 @default.
• W4283588045 hasVolume "32" @default.
• W4283588045 isParatext "false" @default.
• W4283588045 isRetracted "false" @default.
• W4283588045 workType "article" @default.